Skip to main content

Table 1 Characteristic of patients (N = 16)

From: Improvement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study

Demographics

 

Age (years)a

67.0 (58.0-71.0)

Sex (men/women)

11/5

BMI (kg/m2)a

25.0 (22.0-27.9)

Duration of diabetes (years)a

14.0 (8.5-24.75)

HbA1c (%)a

9.1 (8.3-10.4)

Glycated albumin (%)a

22.9 (19.8-26.8)

eGFR (mL/min/1.73 m2)a

70.0 (62.6-82.4)

Previous medication of diabetes

 

Insulinb

7

Oral hypoglycemic agents

 

Sulfonylureab

5

Metforminb

9

Alpha-glucosidase inhibitorb

4

Glinideb

2

DPP-4 inhibitorb

0

Administration of metformin at STEP 0b

10

  1. a: Median (interquartile range), b: Numbers.